ClinicalTrialsFinder

Hormone-refractory Prostate Cancer Clinical Trials in London

1 recruitingLondon, United Kingdom

Showing 1–1 of 1 trials

Recruiting
Phase 1

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Hormone-refractory Prostate Cancer
Vir Biotechnology, Inc.390 enrolled10 locationsNCT05997615